Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—General Average - - - - - - 82,062.92 7,198.83 999.92 4,608.30 -206.50 0.28 22.2529 0.80 59.4775 12.0680 1.33 4.77 101.0370 - -
Maximum - - - - - - 254,201.00 13,765.00 2,179.00 18,021.00 1,154.00 0.89 46.2856 2.71 76.7200 22.0300 2.70 15.33 350.2200 - -
Minimum - - - - - - 0.00 944.00 19.00 0.00 -2,626.00 0.00 0.8741 0.06 6.4100 1.2400 0.00 0.97 0.0000 - -
AbbVie Inc. ABBV 193.29 0.36 0.18% 566 vs. 5,189 341,424.00 12,310.00 1,369.00 3,847.00 -2,384.00 0.7700 58.3938 0.87 66.84 11.12 17.10 0.92 72.29 1,766.00
Gilead Sciences, Inc. GILD 83.88 -0.02 -0.02% 846 vs. 7,032 104,423.00 6,686.00 -4,170.00 2,114.00 10,656.00 -3.3400 -5.4485 1.09 76.79 -62.37 -23.78 -7.41 82.43 1,244.00
Bristol-Myers Squibb Company BMY 49.26 -0.48 -0.97% 1,027 vs. 14,136 99,869.00 11,865.00 -11,911.00 2,550.00 15,640.00 -5.8900 -2.2500 1.13 75.29 -100.39 -72.23 -12.03 91.90 2,027.00
Pfizer Inc. PFE 29.98 0.24 0.79% 2,768 vs. 31,613 169,915.00 14,879.00 3,115.00 387.00 121,318.00 0.5500 12.5852 1.51 70.56 20.94 3.38 1.41 56.59 5,666.00
Amgen Inc. AMGN 338.11 5.19 1.56% 201 vs. 2,056 181,676.00 7,396.00 -113.00 459.00 -27,870.00 -0.2100 -335.6404 0.80 56.73 -1.53 -2.25 -0.12 83.62 537.00
Eli Lilly and Company LLY 908.89 3.92 0.43% 307 vs. 3,176 863,832.00 8,768.00 2,242.00 179.00 12,553.00 2.4900 76.3636 0.17 82.50 25.58 17.51 3.51 67.75 950.00
Merck & Co., Inc. MRK 118.58 -0.06 -0.05% 870 vs. 9,865 300,590.00 15,809.00 4,762.00 2,229.00 56,697.00 1.8800 17.4190 0.59 75.11 30.12 11.80 4.50 72.84 2,534.00
Johnson & Johnson JNJ 165.88 -0.27 -0.16% 481 vs. 6,805 399,318.00 21,382.00 3,255.00 2,850.00 153,378.00 1.3500 29.1832 0.76 68.78 15.22 4.65 1.89 84.48 2,407.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for PFE and its peers to uncover potential buy and sell opportunities.